HR 1525
Protecting Life from Chemical Abortions Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 1:34 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, titled the Protecting Life from Chemical Abortions Act, aims to reverse recent changes made by the Food and Drug Administration (FDA) regarding mifepristone, a medication used in abortion procedures. Specifically, it seeks to reinstate a requirement that mifepristone be dispensed only in clinics, medical offices, or hospitals under the supervision of a certified healthcare provider, effectively limiting mail-order availability. The bill also prohibits the declaration of a public health emergency related to abortion and mandates specific data collection by states for abortion surveillance.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.